Literature DB >> 11830706

The politics of tobacco.

J L Mackay1.   

Abstract

Smoking prevalence and tobacco-attributable mortality will increase substantially in the Asia- Pacific region well into the next century, due to population expansion, ageing populations, and the fact that more women are smoking. The economic costs of tobacco, already substantial, will rise. Of particular concern is the penetration of the region by the transnational tobacco companies, which deny the health evidence of the harm from tobacco, use sophisticated promotions, and lobby to oppose tobacco control measures. There is an urgent need for robust tobacco control action to be taken by every country, but many governments have little experience in combatting this new epidemic or in countering the tobacco companies. They are needlessly concerned that tobacco control action will harm their economy, leading to loss of tax revenue and jobs. Arguments to convince governments must be shaped to address economic issues and illustrate that such action is not only good for a nation's health, but also good for its economy.

Entities:  

Year:  1998        PMID: 11830706

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  3 in total

Review 1.  "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.

Authors:  J Knight; S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

Review 2.  "Asia is now the priority target for the world anti-tobacco movement": attempts by the tobacco industry to undermine the Asian anti-smoking movement.

Authors:  J Knight; S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

3.  Community-Based Screening, Brief Intervention, and Referral for Treatment for Unhealthy Tobacco Use: Single Arm Study Experience and Implementation Success in Rural and Semi-Rural Settings, South-West Nigeria.

Authors:  Victor Olufolahan Lasebikan; Bolanle Adeyemi Ola
Journal:  Front Psychiatry       Date:  2016-08-02       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.